Kotwani Anita
Associate Professor, Department of Pharmacology, V. P. Chest Institute, University of Delhi, Delhi, India, email
Int Psychiatry. 2012 May 1;9(2):34-36. eCollection 2012 May.
This commentary highlights the poor availability of essential psychiatric medicines at public sector facilities in India and illustrates why even a flourishing generics industry does not assure access to affordable psychiatric medicines for most Indian patients. The paper outlines the Indian government's pricing regulations and then enumerates recommendations for reform.
这篇评论强调了印度公共部门医疗机构基本精神科药物供应不足的情况,并说明了为何即便仿制药产业蓬勃发展,大多数印度患者仍无法获得价格可承受的精神科药物。该论文概述了印度政府的定价规定,随后列举了改革建议。